Topics

MIT research shows how strategic gene arrangement on DNA can boost performance of engineered synthetic gene circuits.

Scientists from Purdue and Columbia universities describe an RNA-guided molecular machine that activates gene expression by recruiting the cell’s transcription machinery, offering a gentler alternative to standard gene-cutting tools.

Stanford Medicine's CRISPR-GPT helps researchers plan experiments faster, broadening access to biotech for beginners and experts alike.

Using AI protein modeling and a new screening system, scientists enhance a small DNA-editing enzyme to achieve higher efficiency with less unwanted damage and toxicity.

"NANITE" strategy amplifies genome editing in vivo by turning transfected cells into temporary factories that deliver Cas9 to their neighbors.

Scientists tweak mouse genes to mimic woolly mammoths, aiming to revive ancient species and boost ecosystems.

A powerful AI model predicts how DNA changes affect gene regulation, aiding research into diseases and genome function.

Researchers create a gentle tool to watch how cells fix damaged DNA without interfering, opening new ways to study diseases like cancer.

MIT's DIAL system offers precise, adjustable control over protein expression in synthetic gene circuits to enhance uniform cell reprogramming and enable tailored therapies.

Microsoft's AI reveals vulnerability in systems preventing misuse of genetic material for harmful toxins.